APA (7th ed.) Citation

Samyshkin, Y., Radford, M., Schlunegger, M., & Gooss, A. (2011). PRS39 Cost-Effectiveness of Roflumilast in Combination with Bronchodilator Therapies in Patients with Severe and Very Severe COPD in Switzerland. Value in Health, A494. https://doi.org/10.1016/j.jval.2011.08.1426

Chicago Style (17th ed.) Citation

Samyshkin, Y., M. Radford, M. Schlunegger, and A. Gooss. "PRS39 Cost-Effectiveness of Roflumilast in Combination with Bronchodilator Therapies in Patients with Severe and Very Severe COPD in Switzerland." Value in Health 2011: A494. https://doi.org/10.1016/j.jval.2011.08.1426.

MLA (9th ed.) Citation

Samyshkin, Y., et al. "PRS39 Cost-Effectiveness of Roflumilast in Combination with Bronchodilator Therapies in Patients with Severe and Very Severe COPD in Switzerland." Value in Health, 2011, p. A494, https://doi.org/10.1016/j.jval.2011.08.1426.